第二届中国医师协会泌尿外科医师分会雁栖湖会议
益普生(天津)医药商贸有限公司
公司介绍
产品列表
联系方式

关于益普生

益普生集团成立于1929年,从家族企业到上市集团,我们已走过90余年的历史。 作为全球性生物制药公司,益普生专注于肿瘤学、罕见病和神经科学领域的变革性药物。集团拥有超过20种产品,销售网络遍布于全球110余个国家,并在其中30个国家直接设立了商业公司。 目前益普生在全球范围内拥有约5700名员工,4个研发中心和8个生产工厂。 我们致力于延长患者的生命并改善患者的生活。

益普生集团于1992年进入中国,2019年在上海设立创新中心,是全球四个研发中心之一。益普生特药于2021年在上海成立中国区总部,专注于肿瘤学、罕见病和神经科学领域,携手创新中心持续推出创新治疗方案以满足中国患者亟待解决的治疗需求。

About Ipsen

Founded 1929, Ipsen Group has been a family-owned business for the past 90 year and is a publicly traded business. As a global biopharmaceutical company, Ipsen is focusing on transformative medicines in Oncology, Rare Disease & Neuroscience. We have more than 20 medicines registered in over 110 countries, and we have direct commercial presence in 30 countries. With over 5700 employees, 4 global R&D hubs and 8 manufacturing facilities around the world, we are dedicated to prolonging and improving patients’ lives and health outcomes.

Ipsen begins its development in China in 1992 and set up its Innovation Center in Shanghai in 2019, which is one of its four R&D centers in the world. Ipsen Specialty Care established its China headquarters in Shanghai in 2021, with a focus on Oncology, Rare Diseases, and Neuroscience. Together with the Innovation Center, Ipsen Specialty Care China continues to introduce innovative medical solutions for the unmet medical needs of Chinese patients.